A detailed history of Fore Capital, LLC transactions in Bausch & Lomb Corp stock. As of the latest transaction made, Fore Capital, LLC holds 52,614 shares of BLCO stock, worth $946,525. This represents 0.48% of its overall portfolio holdings.

Number of Shares
52,614
Previous 42,180 24.74%
Holding current value
$946,525
Previous $612,000 65.69%
% of portfolio
0.48%
Previous 0.52%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$14.59 - $20.0 $152,232 - $208,680
10,434 Added 24.74%
52,614 $1.01 Million
Q2 2024

Aug 07, 2024

BUY
$13.6 - $17.06 $272,000 - $341,200
20,000 Added 90.17%
42,180 $612,000
Q1 2024

May 07, 2024

BUY
$13.68 - $17.6 $303,422 - $390,368
22,180 New
22,180 $383,000
Q4 2022

Feb 13, 2023

SELL
$13.5 - $17.14 $244,917 - $310,953
-18,142 Reduced 34.14%
35,000 $542,000
Q3 2022

Nov 10, 2022

BUY
$14.23 - $17.76 $756,210 - $943,801
53,142 New
53,142 $815,000

Others Institutions Holding BLCO

About Bausch & Lomb Corp


  • Ticker BLCO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 350,000,000
  • Market Cap $6.3B
  • Description
  • Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replace...
More about BLCO
Track This Portfolio

Track Fore Capital, LLC Portfolio

Follow Fore Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fore Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fore Capital, LLC with notifications on news.